US Stock MarketDetailed Quotes

DMKPQ DMK Pharmaceuticals

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayTrading Sep 13 16:00 ET
2.02KMarket Cap0.00P/E (TTM)

DMK Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
49.27%-3.75M
74.14%-2.54M
78.91%-1.42M
33.58%-25.51M
72.44%-1.57M
46.45%-7.39M
37.29%-9.84M
-108.46%-6.71M
-132.41%-38.41M
-25.21%-5.71M
Net income from continuing operations
68.45%-1.39M
-2.11%-8.57M
13.63%-8.94M
42.22%-26.48M
62.08%-3.33M
64.41%-4.4M
9.84%-8.4M
32.67%-10.35M
7.21%-45.83M
50.87%-8.77M
Operating gains losses
-1,213.19%-770.72K
-19,773.92%-3.88M
26,454.58%2.47M
-101.22%-92.16K
95.57%-4.55K
-38.02%-58.69K
-144.84%-19.54K
-100.12%-9.39K
1,721.57%7.54M
97.15%-102.64K
Depreciation and amortization
-83.16%67.19K
-76.29%87.35K
-68.19%109.47K
3.33%1.48M
2.22%372.01K
6.41%398.99K
-0.16%368.36K
4.96%344.16K
-38.36%1.44M
-36.75%363.91K
Other non cash items
-434.18%-413.26K
2,219.92%8.1M
-113.07%-78.5K
-79.79%1.26M
-4.80%913.17K
-94.33%123.67K
-124.60%-382.26K
-60.39%600.83K
-56.83%6.21M
-83.98%959.25K
Change In working capital
63.03%-1.32M
281.05%1.67M
111.69%4.95M
87.58%-1.34M
-35.27%799.4K
16.82%-3.56M
90.14%-922.74K
46.45%2.34M
-254.85%-10.8M
-78.65%1.24M
-Change in receivables
--0
--0
234.36%1.05M
96.19%-269.44K
-765.87%-697.92K
76.41%-1.58M
1,007.11%2.8M
-1,942.73%-784.52K
-2,275.12%-7.07M
70.15%-80.6K
-Change in inventory
100.20%1.4K
--0
45.78%574.42K
-247.30%-820.17K
83.28%-146.33K
-211.39%-681.25K
-134.90%-386.62K
104.95%394.03K
86.68%-236.15K
53.78%-875.39K
-Change in prepaid assets
1,910.89%137.19K
-76.74%47.15K
204.85%1.13M
-535.20%-513.51K
-149.17%-1.08M
-100.88%-7.58K
120.74%202.77K
-20.35%371.91K
84.38%-80.84K
-231.19%-433.68K
-Change in payables and accrued expense
-152.51%-1.27M
702.13%1.59M
345.18%2.37M
0.64%2.6M
336.15%2.83M
-150.65%-502.76K
-1,443.85%-263.29K
-42.19%532.99K
161.05%2.58M
351.54%649.67K
-Change in other current liabilities
9.39%-175.19K
101.39%45.04K
-109.49%-175.65K
71.28%-1.69M
-105.12%-102.32K
---193.35K
58.88%-3.25M
--1.85M
-174.68%-5.9M
-74.68%2M
-Change in other working capital
98.46%-9.06K
72.22%-6.94K
72.22%-6.95K
-543.97%-643.97K
72.22%-6.94K
-2,248.12%-587.03K
-5.62%-25K
5.05%-25K
-300.00%-100K
0.00%-25K
Cash from discontinued investing activities
109.58%10.52K
57.81%-24.79K
51.57%-131.16K
-161.96%-387.88K
105.33%51.42K
-102.72%-109.74K
94.78%-58.74K
79.41%-270.82K
114.31%626.05K
-13.22%-964.26K
Operating cash flow
50.16%-3.74M
74.04%-2.57M
77.85%-1.55M
31.45%-25.9M
77.19%-1.52M
23.23%-7.5M
41.13%-9.89M
-53.98%-6.99M
-80.78%-37.79M
-23.32%-6.67M
Investing cash flow
Cash flow from continuing investing activities
-99.98%124
-86.40%138.29K
-99.36%9.78K
1,749.29%3.41M
-92.21%81.86K
4,134.07%779.22K
330.20%1.02M
477.98%1.53M
126.33%184.42K
3,341.21%1.05M
Net PPE purchase and sale
--0
--0
--0
44.39%-680.42K
59.73%-91.49K
-39.31%-207.76K
19.79%-354.24K
93.36%-26.93K
-171.60%-1.22M
-843.93%-227.18K
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net other investing changes
-99.99%124
-99.84%2.2K
-99.37%9.78K
190.57%4.09M
-86.44%173.35K
--986.98K
--1.37M
--1.56M
--1.41M
--1.28M
Cash from discontinued investing activities
Investing cash flow
126.82%1.77M
-86.40%138.29K
-45.08%841.78K
1,132.21%3.48M
-86.67%155.3K
2,350.39%779.22K
330.20%1.02M
477.34%1.53M
129.88%282.74K
6,204.13%1.17M
Financing cash flow
Cash flow from continuing financing activities
1,738.04%5.24M
2.73M
2.72M
-99.49%285K
0
285K
0
0
180.42%56.04M
0
Net issuance payments of debt
----
----
----
--0
--0
----
----
----
-44.68%1.77M
--0
Net common stock issuance
--0
----
----
--0
--0
--0
----
----
183.90%51.75M
--3.33M
Net preferred stock issuance
----
----
----
--300K
--15K
----
----
----
--0
--0
Proceeds from stock option exercised by employees
--870.79K
---2.1M
--3M
--0
--0
--0
--0
--0
--5.85M
--0
Net other financing activities
---912.75K
--0
---275K
99.55%-15K
----
----
----
----
-131.82%-3.33M
----
Cash from discontinued financing activities
0
0
0
0
0
-2,218.25%-2.1M
-63.57%-42.85K
Financing cash flow
2,694.18%7.96M
--750
--2.72M
-99.47%285K
--0
114.20%285K
--0
--0
171.14%53.94M
66.71%-42.85K
Net cash flow
Beginning cash position
-92.47%670.34K
-82.41%3.13M
-95.22%1.11M
244.51%23.25M
-91.48%2.45M
-77.92%8.91M
-69.12%17.8M
239.16%23.25M
-19.83%6.75M
138.83%28.76M
Current changes in cash
193.16%5.99M
72.63%-2.43M
137.02%2.02M
-234.68%-22.13M
75.38%-1.37M
45.52%-6.43M
48.61%-8.88M
-110.68%-5.45M
940.46%16.43M
-0.53%-5.55M
End cash Position
171.99%6.66M
-92.47%670.34K
-82.41%3.13M
-95.22%1.11M
-95.22%1.11M
-91.48%2.45M
-77.92%8.91M
-69.12%17.8M
244.51%23.25M
244.51%23.25M
Free cash flow
51.50%-3.74M
74.94%-2.57M
77.93%-1.55M
31.86%-26.58M
76.62%-1.61M
22.29%-7.71M
40.59%-10.25M
-41.89%-7.01M
-80.58%-39.01M
-28.24%-6.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 49.27%-3.75M74.14%-2.54M78.91%-1.42M33.58%-25.51M72.44%-1.57M46.45%-7.39M37.29%-9.84M-108.46%-6.71M-132.41%-38.41M-25.21%-5.71M
Net income from continuing operations 68.45%-1.39M-2.11%-8.57M13.63%-8.94M42.22%-26.48M62.08%-3.33M64.41%-4.4M9.84%-8.4M32.67%-10.35M7.21%-45.83M50.87%-8.77M
Operating gains losses -1,213.19%-770.72K-19,773.92%-3.88M26,454.58%2.47M-101.22%-92.16K95.57%-4.55K-38.02%-58.69K-144.84%-19.54K-100.12%-9.39K1,721.57%7.54M97.15%-102.64K
Depreciation and amortization -83.16%67.19K-76.29%87.35K-68.19%109.47K3.33%1.48M2.22%372.01K6.41%398.99K-0.16%368.36K4.96%344.16K-38.36%1.44M-36.75%363.91K
Other non cash items -434.18%-413.26K2,219.92%8.1M-113.07%-78.5K-79.79%1.26M-4.80%913.17K-94.33%123.67K-124.60%-382.26K-60.39%600.83K-56.83%6.21M-83.98%959.25K
Change In working capital 63.03%-1.32M281.05%1.67M111.69%4.95M87.58%-1.34M-35.27%799.4K16.82%-3.56M90.14%-922.74K46.45%2.34M-254.85%-10.8M-78.65%1.24M
-Change in receivables --0--0234.36%1.05M96.19%-269.44K-765.87%-697.92K76.41%-1.58M1,007.11%2.8M-1,942.73%-784.52K-2,275.12%-7.07M70.15%-80.6K
-Change in inventory 100.20%1.4K--045.78%574.42K-247.30%-820.17K83.28%-146.33K-211.39%-681.25K-134.90%-386.62K104.95%394.03K86.68%-236.15K53.78%-875.39K
-Change in prepaid assets 1,910.89%137.19K-76.74%47.15K204.85%1.13M-535.20%-513.51K-149.17%-1.08M-100.88%-7.58K120.74%202.77K-20.35%371.91K84.38%-80.84K-231.19%-433.68K
-Change in payables and accrued expense -152.51%-1.27M702.13%1.59M345.18%2.37M0.64%2.6M336.15%2.83M-150.65%-502.76K-1,443.85%-263.29K-42.19%532.99K161.05%2.58M351.54%649.67K
-Change in other current liabilities 9.39%-175.19K101.39%45.04K-109.49%-175.65K71.28%-1.69M-105.12%-102.32K---193.35K58.88%-3.25M--1.85M-174.68%-5.9M-74.68%2M
-Change in other working capital 98.46%-9.06K72.22%-6.94K72.22%-6.95K-543.97%-643.97K72.22%-6.94K-2,248.12%-587.03K-5.62%-25K5.05%-25K-300.00%-100K0.00%-25K
Cash from discontinued investing activities 109.58%10.52K57.81%-24.79K51.57%-131.16K-161.96%-387.88K105.33%51.42K-102.72%-109.74K94.78%-58.74K79.41%-270.82K114.31%626.05K-13.22%-964.26K
Operating cash flow 50.16%-3.74M74.04%-2.57M77.85%-1.55M31.45%-25.9M77.19%-1.52M23.23%-7.5M41.13%-9.89M-53.98%-6.99M-80.78%-37.79M-23.32%-6.67M
Investing cash flow
Cash flow from continuing investing activities -99.98%124-86.40%138.29K-99.36%9.78K1,749.29%3.41M-92.21%81.86K4,134.07%779.22K330.20%1.02M477.98%1.53M126.33%184.42K3,341.21%1.05M
Net PPE purchase and sale --0--0--044.39%-680.42K59.73%-91.49K-39.31%-207.76K19.79%-354.24K93.36%-26.93K-171.60%-1.22M-843.93%-227.18K
Net business purchase and sale --0------------------0----------------
Net other investing changes -99.99%124-99.84%2.2K-99.37%9.78K190.57%4.09M-86.44%173.35K--986.98K--1.37M--1.56M--1.41M--1.28M
Cash from discontinued investing activities
Investing cash flow 126.82%1.77M-86.40%138.29K-45.08%841.78K1,132.21%3.48M-86.67%155.3K2,350.39%779.22K330.20%1.02M477.34%1.53M129.88%282.74K6,204.13%1.17M
Financing cash flow
Cash flow from continuing financing activities 1,738.04%5.24M2.73M2.72M-99.49%285K0285K00180.42%56.04M0
Net issuance payments of debt --------------0--0-------------44.68%1.77M--0
Net common stock issuance --0----------0--0--0--------183.90%51.75M--3.33M
Net preferred stock issuance --------------300K--15K--------------0--0
Proceeds from stock option exercised by employees --870.79K---2.1M--3M--0--0--0--0--0--5.85M--0
Net other financing activities ---912.75K--0---275K99.55%-15K-----------------131.82%-3.33M----
Cash from discontinued financing activities 00000-2,218.25%-2.1M-63.57%-42.85K
Financing cash flow 2,694.18%7.96M--750--2.72M-99.47%285K--0114.20%285K--0--0171.14%53.94M66.71%-42.85K
Net cash flow
Beginning cash position -92.47%670.34K-82.41%3.13M-95.22%1.11M244.51%23.25M-91.48%2.45M-77.92%8.91M-69.12%17.8M239.16%23.25M-19.83%6.75M138.83%28.76M
Current changes in cash 193.16%5.99M72.63%-2.43M137.02%2.02M-234.68%-22.13M75.38%-1.37M45.52%-6.43M48.61%-8.88M-110.68%-5.45M940.46%16.43M-0.53%-5.55M
End cash Position 171.99%6.66M-92.47%670.34K-82.41%3.13M-95.22%1.11M-95.22%1.11M-91.48%2.45M-77.92%8.91M-69.12%17.8M244.51%23.25M244.51%23.25M
Free cash flow 51.50%-3.74M74.94%-2.57M77.93%-1.55M31.86%-26.58M76.62%-1.61M22.29%-7.71M40.59%-10.25M-41.89%-7.01M-80.58%-39.01M-28.24%-6.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data